Royce & Associates’s Doximity DOCS Stock Holding History

Royce & Associates’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-145,387	Closed	-$4.08M	–	887
2023 Q4	$4.08M	Buy	145,387 +63,818	+78%	+$1.51M	0.04%	531
2023 Q3	$1.73M	Buy	81,569 +3,554	+5%	+$97K	0.02%	664
2023 Q2	$2.65M	Sell	78,015 -207,355	-73%	-$6.9M	0.03%	626
2023 Q1	$9.24M	Buy	285,370 +139,210	+95%	+$4.62M	0.09%	332
2022 Q4	$4.91M	Sell	146,160 -234,868	-62%	-$7.17M	0.05%	474
2022 Q3	$11.5M	Buy	381,028 +242,683	+175%	+$8.89M	0.13%	236
2022 Q2	$4.82M	Buy	138,345 +124,225	+880%	+$4.89M	0.05%	483
2022 Q1	$736K	Sell	14,120 -1,000	-7%	-$50.3K	0.01%	837
2021 Q4	$758K	Buy	15,120 +470	+3%	+$30.6K	0.01%	839
2021 Q3	$1.18M	Buy	14,650 +6,700	+84%	+$490K	0.01%	799
2021 Q2	$463K	Buy	+7,950	New	+$446K	﹤0.01%	937

Other funds holding DOCS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Royce & Associates's DOCS Position: Q1 2024 in Review

Royce & Associates sold out of Doximity (DOCS) in Q1 2024, closing a stake of 145,387 shares — an estimated $4.08M sold.

Royce & Associates first reported a position in DOCS in Q2 2021 and held it in 11 quarters. The position peaked at $11.5M in Q3 2022. 336 funds tracked by Wall St. Rank hold DOCS as of Q1 2024.

Royce & Associates reported no remaining Doximity position as of Q1 2024 after selling out during the quarter.
Royce & Associates sold 145,387 Doximity shares in Q1 2024, an estimated $4.08M.
Royce & Associates first reported a position in Doximity in Q2 2021 and held it in 11 quarters.
Royce & Associates's Doximity position peaked at $11.5M in Q3 2022.
336 funds tracked by Wall St. Rank held Doximity as of Q1 2024.

Based on Royce & Associates's 13F filing for Q1 2024, filed 13 May 2024.